*Hidefumi Suzuki1,2,3, Naohiro Egawa1,2,3, Keiko Imamura2,3,4, Takayuki Kondo2,3,4, Takako Enami2,4, Kayoko Tsukita2,3, Mika Suga2,3, Yuichiro Yada2,3, Ran Shibukawa3, Ryosuke Takahashi1, Haruhisa Inoue2,3,4
(1. Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2. Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan, 3. iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan, 4. Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan)
Keywords:synucleinopathy, cortical neurons, MAPK cascade